Stockreport

NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain Compliance with Bid Price Requirement

China SXT Pharmaceuticals, Inc.  (SXTC) 
PDF TAIZHOU, China, Sept. 9, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing [Read more]